Cell Counting Market to Grow with a CAGR of 8.00% through 2028
Advances in cell-based research and the increasing
role of cell counting in clinical diagnostics is expected to drive the Global Cell
Counting Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Cell
Counting Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Cell Counting Market stood
at USD 8.19 billion in 2022 and is anticipated to grow with a CAGR of 8.00% in
the forecast period, 2024-2028. This can be attributed to growth in clinical
diagnostics. Cell counting is not limited to research and biopharmaceutical
applications. Clinical diagnostics, including hematology, pathology, and cancer
research, rely on accurate cell counting to make critical medical decisions.
The increasing prevalence of chronic diseases and the need for precise cell
counting in diagnostic tests are contributing to the market's growth. Automated
hematology analyzers and flow cytometry systems are becoming indispensable
tools in healthcare institutions, aiding in the rapid and accurate analysis of
blood samples and cell populations.
Furthermore, biopharmaceutical companies are
increasingly relying on cell counting for bioprocessing and quality control.
This trend ensures the consistency and quality of biologic products, such as
monoclonal antibodies and vaccines. As biopharmaceuticals continue to grow, so
does the demand for advanced cell counting solutions.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Cell Counting Market”
The market experienced a significant impact from the
COVID-19 pandemic. The utilization of cell counting devices saw a notable surge
during the pandemic, primarily because conditions like lymphopenia and
osteopenia were potential indicators of COVID-19. Furthermore, a study
published by BMC in June 2021 established a significant correlation between the
white blood cell (WBC) count of COVID-19 patients upon admission and their
likelihood of mortality. Patients with higher white blood cell counts required
extra attention in their COVID-19 treatment. The growing significance of cell
counting in managing COVID-19 patients contributed to market growth during the
pandemic. Cell counting instruments are increasingly finding applications in
various research fields such as neuroscience, cancer biology, and immunology,
offering promising growth opportunities for the market.
Cell counting plays a crucial role in identifying and
quantifying primary tumors, circulating tumors, and metastatic tumors, which
are vital for disease monitoring and therapeutic targeting. Additionally, they
are extensively employed in cancer research to assess intra-tumor
heterogeneity, a critical factor in determining cancer progression. The
adoption of cell counting is anticipated to rise over the forecast period as it
is essential for diagnosing various diseases.
Moreover, technological advancements in these devices
present lucrative opportunities during the study period. For example, in
January 2023, DeNovix's automated cell counter, CellDrop, received recognition
as the Sustainable Laboratory Product of the Year in the SelectScience
Scientists' Choice Awards. This accolade is due to its innovation in
eliminating the need for cell counting slides, resulting in the conservation of
8.5 million slides, equivalent to 30,000 kg of plastic. In April 2021,
CytoSMART Technologies launched their first fluorescence cell counter,
CytoSMART Exact FL, offering dual fluorescence capabilities for typical
laboratory applications. In December 2020, Merck introduced Scepter 3.0, an
automated handheld cell counter known for its remarkable accuracy in counting
thousands of cells per measurement. Similarly, in June 2020, DeNovix introduced
the industry's first imaging cell counter, which eliminates the requirement for
slides, thereby reducing the environmental impact of laboratory operations.
Government initiatives aimed at promoting cell
therapeutics research are expanding growth opportunities in the market.
Additionally, increased funding for stem cell research in recent years has
accelerated research efforts. For instance, in March 2023, the Stem Cell
Research and the Eli and Edythe Broad Center of Regenerative Medicine at UCLA
received more than USD 5.7 million in funding from the California Institute for
Regenerative Medicine to enhance stem cell-based technologies for treating
cancer and intellectual disabilities.
The Global Cell Counting Market is segmented into product,
application, end-use, regional distribution, and company.
Based on its product, the consumables and accessories
sector dominated the revenue landscape in 2022, and it is poised to exhibit the
most rapid CAGR throughout the projected period. These consumables and
accessories encompass various items such as reagents, microplates, magnetic
beads, and chamber slides, all of which are used in conjunction with specific
devices. The upswing in demand for these consumables and accessories can be
attributed to their significant usage frequency. Additionally, the introduction
of innovative products has been a driving force behind the growth of this
segment. As an illustrative example, eNuvio launched a reusable 3D cell culture
microplate in December 2020, with the expectation that scientists would reap
both economic and scientific benefits from this environmentally friendly device
for an extended duration.
Furthermore, within this segment, the reagents
sub-category claimed the largest portion of revenue in 2022. This substantial
revenue share can be attributed to the recurring procurement of these products
for applications in spectrophotometry, flow cytometry, and automated cell
counting. The necessity for frequent recalibrations of these instruments before
conducting experiments has bolstered their demand. Notably, Corning's automated
Cell Counter simplifies this process by seamlessly connecting the device with a
tablet or computer via the CytoSMART Cloud App. This system promptly generates
summary reports after each count, which can be conveniently accessed remotely
on various devices.
Based on end-use, the major chunk of the revenue was
contributed by research and academic institutions. The primary reason for this
dominant position can be traced back to the widespread adoption of cytometers
in cell biology research endeavors. Cytometers serve various purposes,
including measuring physical characteristics, cell types, and lineages. These
measurements are pivotal for researchers in studying the progression of
viruses, pathogens, and other microorganisms. Additionally, the proactive
initiatives taken by key players in the market further bolster this segment. As
an example, in March 2021, Alliance Global successfully implemented an
Automated Cell Counter system at the United Arab Emirates University in Al Ain.
Conversely, the hospitals and diagnostic laboratories
sector is expected to exhibit a significant CAGR over the forecast period. This
growth can be attributed to the substantial foot traffic in hospitals and the
increasing adoption of advanced technological devices in diagnostic
laboratories. In July 2021, Neuberg Diagnostics Private Limited, a prominent
pathology organization in India, expanded its presence in the country by
inaugurating a pathology lab in Telangana.
Furthermore, the pharmaceutical and biotechnology
companies sector is anticipated to experience the fastest CAGR during the
forecast period. Cell counting holds a crucial role in assessing the potency of
any biological product. These devices are employed to ascertain the cell count
in a specific culture solution, which is subsequently introduced into
bioreactors and fermenters to achieve the desired end product. The growing
demand for biologics manufactured through bioprocessing in these bioreactors
and fermenters is expected to drive increased demand for these devices in the
coming years.
Major companies operating in Global Cell Counting
Market are:
- Thermo Fisher Scientific Inc
- Merck KGaA
- Agilent Technologies, Inc.
- PerkinElmer Health Sciences Inc
- Becton Dickinson & Co
- Danaher Corp
- Bio-Rad Laboratories Inc
- BioTek Instruments Inc
- GE Healthcare Inc
- deNovis Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“the global cell counting market is witnessing
exciting trends that are shaping the future of this essential technology. The
trends are enhancing precision, accessibility, and applications across a wide
range of industries, from healthcare to biotechnology and environmental
science. As technology continues to advance and as new challenges arise, the
global cell counting market will remain at the forefront of innovation, playing
a pivotal role in the advancement of science and healthcare,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Cell Counting Market By Product
(Instruments (Spectrophotometers, Flow Cytometers, Hemocytometers, Automated
cell counters, Microscopes, Others), Consumables & Accessories (Reagents,
Microplates, Others)), By Application (Complete Blood Count (Automated,
Manual), Stem Cell Research, Cell Based Therapeutics, Bioprocessing,
Toxicology, Others), By End-use (Hospitals &Diagnostic Laboratories,
Research & Academic Institutes, Pharmaceutical & Biotechnology
Companies, Others), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Cell Counting Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Cell Counting Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com